Track Tien Liang BioTech , Ltd.'s current cash ($170M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 4127.TWO shows a current cash of $170M. That compares with $160M in the prior-year period — up 3.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4127.TWO's current cash is now $170M (was $160M) — a 3.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tien Liang BioTech , Ltd. is outperforming or lagging.
Tracking 4127.TWO's current cash over time shows whether Tien Liang BioTech , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $160M in the prior-year period — up 3.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Tien Liang BioTech , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170M) with ownership activity and broader fundamentals.